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Abstract
The trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) spike is 
a molecular machine that mediates virus entry into host cells and is the sole target for virus-
neutralizing antibodies. The mature Env spike results from cleavage of a trimeric gp160 precursor 
into three gp120 and three gp41 subunits. Here we describe an ~11-Å cryo-EM structure of the 
trimeric HIV-1 Env precursor in its unliganded state. The three gp120 and three gp41 subunits 
form a cage-like structure with an interior void surrounding the trimer axis. Interprotomer contacts 
are limited to the gp41 transmembrane region, the torus-like gp41 ectodomain, and a gp120 trimer 
association domain composed of the V1/V2 and V3 variable regions. The cage-like architecture, 
which is unique among characterized viral envelope proteins, restricts antibody access, reflecting 
requirements imposed by HIV-1 persistence in the host.
Human immunodeficiency virus type (HIV-1) establishes persistent infections in humans 
that often lead to depletion of CD4+ T lymphocytes and acquired immunodeficiency 
syndrome (AIDS). To infect human T lymphocytes, HIV-1 utilizes a trimeric envelope 
glycoprotein (Env) spike on the virion surface to engage the host receptors, CD4 and a 
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chemokine receptor (either CCR5 or CXCR4), and to fuse the viral and target cell 
membranes1,2. During synthesis and folding in virus-producing cells, the Env precursors 
trimerize and are heavily modified by N-linked glycosylation3,4. HIV-1 Env is one of the 
most heavily glycosylated proteins in nature; each Env protomer usually contains 27 or more 
glycosylation sites, three to five times more than the number of glycosylation sites found in 
other viral envelope glycoproteins. In the Golgi complex, the gp160 Env precursor is 
cleaved into a gp120 exterior subunit and a gp41 transmembrane subunit by a host furin 
protease3,4. Proteolytic cleavage renders the Env trimer competent for membrane fusion, and 
occurs immediately prior to cell surface expression and incorporation into virus particles. 
The Env spike on the virion surface is the only virus-specific component potentially 
accessible to neutralizing antibodies5. A typical HIV-1 virion contains only 10-14 Env 
spikes, so each spike must defend itself against antibody binding. The dense ‘glycan shield’ 
and a high degree of interstrain structural variability help the Env trimer to evade the 
humoral immune response4.
The sequential binding of gp120 to the target cell receptors, CD4 and the chemokine 
receptor, triggers Env transitions from the unliganded state to ‘fusion-ready’ 
conformations4. CD4 binding results in the formation and exposure of two Env elements: 
the gp120 chemokine receptor-binding site and a trimeric gp41 coiled coil. The resulting 
‘pre-hairpin intermediate’ binds the chemokine receptor, and the hydrophobic ‘fusion 
peptide’ at the amino terminus of gp41 is thought to insert into the target cell membrane. 
The collapse of the pre-hairpin intermediate into a stable six-helix bundle results in the 
fusion of viral and cell membranes. Previous studies using xray crystallography have 
revealed the structure of the monomeric gp120 core, in most cases with the V1/V2 and V3 
variable regions deleted, in the CD4-bound state6-8. The gp41 ectodomain, with truncations 
of the fusion peptide and disulfide-bonded loop, crystallized as a six-helix bundle, which 
likely represents the end-stage, post-fusion conformation9-11. The energetically stable six-
helix bundle is composed of a trimeric coiled coil derived from the gp41 heptad repeat 
(HR1) region, with helices derived from the gp41 HR2 region packed against the coiled coil 
in an antiparallel fashion. The structure of the HIV-1 Env trimer complex in its unliganded 
state, which represents the major target for most neutralizing antibodies, is poorly defined. 
Despite extensive efforts, heavy glycosylation, structural plasticity and lability have 
frustrated attempts to obtain a high-resolution structure of the HIV-1 Env trimer. Cryo-
electron tomography of virion Env spikes and cryo-electron microscopy (cryo-EM) analysis 
of purified Env variants have yielded structural models at 20-30 Å resolution12-18. At this 
resolution, the organization of the assembled gp120 and gp41 subunits in the trimer could 
not be assessed. We applied single-particle cryo-EM analysis19 to reconstruct an ~11-Å 
structure of a membrane-bound HIV-1 Env trimer, including the complete exterior and 
transmembrane regions, in an unliganded state. The improved details in our cryo-EM 
structure reveal the architectural organization of gp120 and gp41 subunits in an unliganded 
trimeric Env precursor. The new HIV-1 Env trimer structure allows a better understanding 
of the function of this molecular machine and provides insights into the mechanism of 
HIV-1 entry and immune evasion.
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RESULTS
Structure determination
The Env glycoprotein derived from a primary, neutralization-resistant (Tier 2) clade B 
isolate, HIV-1JR-FL, was chosen for this study. The gp120-gp41 proteolytic cleavage site in 
the HIV-1JR-FL Env was eliminated by two single-residue changes (R508S and R511S in 
standard HXB2 numbering). To improve the expression level on the cell surface, the gp41 
cytoplasmic tail was truncated starting from Tyr712. The modified Env, designated 
Env(−)ΔCT, thus contains the complete ectodomain and transmembrane regions, and was 
purified from the plasma membrane of Env-expressing cells after solubilization in Cymal-5 
detergent (see Methods). This procedure ensures that the purified Env(−)ΔCT trimers derive 
from membrane-bound Env complexes that are glycosylated and have passed the quality-
control checkpoints of the secretory pathway3,4. Importantly, HIV-1 Env(−)ΔCT complexes 
purified in this manner retain epitopes that are dependent upon conformation, glycosylation 
and quaternary structure (Supplementary Fig. 1). The detergent Cymal-5 was exchanged to 
Cymal-6 before preparation for cryo-EM imaging. The membrane glycoprotein, under the 
protection of Cymal-6, was flash-frozen on holey carbon film-coated EM grids and cryo-EM 
image data were collected at liquid nitrogen temperature. The imaging quality was found to 
be critically affected by the choice of the detergent and its concentration in the vitrified 
cryo-EM samples. A dataset of 90,306 single-particle images was assembled and subjected 
to multivariate data analysis, maximum-likelihood alignment and classification19-21. An 
initial model was generated by angular reconstitution from two-dimensional class averages 
refined by a maximum-likelihood approach20,21. The model was then further refined by a 
projection-matching algorithm to a final resolution of 10.8 Å, measured by Fourier shell 
correlation (FSC) with a 0.5-cutoff criterion22 (see Supplementary Figs. 2-5 for more 
technical details).
Overall architecture
The HIV-1JR-FL Env(−)ΔCT complex resembles a triangular pyramid, with an overall 
tetrahedral shape and a remarkable central empty space (Fig. 1 and Supplementary Movie 
1). The transmembrane domain of gp41 shows three lobes that associate at the trimer axis. 
Extending from the viral membrane, each protomer projects approximately 30° away from 
the trimer axis. Narrow interprotomer joints at the base of each projection suggest 
interactions among the gp41 ectodomains. At the membrane-distal end of the Env complex, 
each protomeric ‘leaf’ turns approximately 90° towards the trimer axis and there participates 
in a six-way junction at the gp120-gp120 interfaces.
The cryo-EM reconstruction appears to be of sufficient quality to permit map segmentations 
that make biological sense and are compatible with available structural information. Each 
Env protomer can be segmented into eight sub-structures (Fig. 2). Limited by the resolution 
of the reconstruction itself, the map segmentation may not precisely define the interfaces 
between structural subunits and domains. Nonetheless, the overall subunit definitions 
conveyed by the segments are instructive. The gp41 transmembrane domain and the gp41 
ectodomain clearly partitioned into discrete segments, and two gp41 ectodomain segments 
were defined. The inner domain and outer domain of gp120 are also visible in two 
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segmented sub-structures adjacent to the more distal gp41 ectodomain segment. The rest of 
the gp120 segmentation appears as two arms extending from the gp120 inner and outer 
domains toward a central triangular junction at the gp120 trimer axis (Figs. 1d and 2c).
gp120 inner and outer domains
The spatial relationship between the gp120 outer domain and inner domain is apparent in the 
density map, although at this resolution it is not possible to distinguish any secondary 
structures within the domains. The size and shape of the gp120 segments corresponding to 
the inner domain and outer domain are consistent with those seen in xray crystal structures 
(compare Fig. 2a-c with Fig. 3a,b). Interestingly, the cryo-EM reconstruction clearly shows 
a cavity at the interface between the gp120 outer domain and inner domain. This prominent 
cavity is reminiscent of a similar feature observed in the crystal structure of the CD4-bound 
gp120 core monomer8, and also provides a structural constraint for fitting the crystal 
structure of the gp120 core into the cryo-EM map. Indeed, the crystal structure of the CD4-
bound gp120 core8 was fitted as a rigid body into the cryo-EM map, with a good agreement 
on the position of the inter-domain cavity (Fig. 3a). In this fitting configuration, the gp120 
inner domain in its CD4-bound state fit the density well (Fig. 3a,b); however, the gp120 
outer domain fit less well, as can be best appreciated when viewed from the perspective of 
the target cell (Fig. 3b). The crystal structure of the gp120 outer domain (in the CD4-bound 
state) alone fit well as a rigid body into the cryo-EM map in a slightly different fitting 
configuration (Fig. 3c,d). However, in this case, the associated CD4-bound inner domain 
structure was out of fit (not shown). Thus, the crystal structures of the inner domain and 
outer domain cannot simultaneously fit the cryo-EM map while the CD4-bound state of 
gp120 is maintained. These observations support the existence of conformational differences 
between the unliganded and CD4-bound states in the Env trimer. In fact, there is a 
substantial body of literature documenting a major conformational change in the gp120 
subunit upon CD4 binding14-17,23-28. Our analysis is consistent with this notion and suggests 
that CD4 engagement modifies the spatial relationship between the gp120 inner domain and 
outer domain.
The outer domain in the crystal structure of an unliganded gp120 core monomer from simian 
immunodeficiency virus (SIV)29 also fit very well into our cryo-EM map in the same fitting 
configuration as that used for the CD4-bound HIV-1 gp120 core. However, in this 
configuration, the inner domain of the SIV gp120 core did not fit the cryo-EM map. 
Apparently, the unliganded gp120 structure differs between SIV in the monomeric form and 
HIV-1 in the trimeric form.
At a higher level of contour in the cryo-EM map, the weak density linking the gp120 inner 
domain and outer domain at the midpoint of the interdomain interface agrees with the 
location of interdomain strands in the CD4-bound gp120 core structure6-8. Taken together, 
the structural consistency between the cryo-EM density map and previously reported x-ray 
crystallography data provides an independent check on the reconstruction accuracy and 
resolution estimation of the cryo-EM model.
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gp120 trimer association
The cryo-EM map exhibits rich features around the gp120-gp120 interfaces, revealing that 
the interprotomer contacts among the gp120 subunits involve a six-way junction (Fig. 4a). 
Two elongated arm-like elements extend from the core of each gp120 subunit toward the 
trimer axis. One arm originates in the gp120 outer domain at the base of the V3 variable 
region and terminates about 1.7 nm away from the trimer center. The V3 variable region, 
which is flanked by disulfide-bonded cysteine residues at its base, likely contributes to this 
arm. The other arm extends from the gp120 inner domain and points directly at the trimer 
axis (Fig. 4b, c). This arm likely contains the V1/V2 stem, which is composed of two 
antiparallel β-strands stabilized at both ends by disulfide bonds6. The V1/V2 stem projects ~ 
2.7 nm from the inner domain and serves as a point of origin and return for the V1 and V2 
variable regions. At the gp120 trimer center, a triangular junction about 1.5 nm across points 
its apex toward the target cell (Fig. 4a). The interprotomer contacts among the three gp120 
subunits involve this central triangular junction and the six arms; together, these structures 
can account for the expected mass of the gp120 V1/V2 and V3 regions. These results agree 
with recent electron tomography studies of wild-type and V1/V2-truncated HIV-1 Env 
spikes18, which suggested that the V1/V2 regions reside in the membrane-distal apex of the 
spike.
The V1/V2 and V3 variable regions have been speculated to be highly disordered in the 
unliganded state of HIV-1 Env. This speculation is not supported by our cryo-EM map. If 
the structure of these variable regions is mostly disordered in the unliganded state, the 
averaging of cryo-EM single-particle projections should eliminate or substantially weaken 
their corresponding density. On the contrary, our cryo-EM map exhibits a very stable 
reconstruction of the central triangle and six-arm junction that is very unlikely to be 
accounted for by disordered conformations. Our analysis instead favors the possibility that 
the V1/V2 and V3 regions of gp120 fold into a relatively stable structure. Such a model 
likely explains the observation that, in primary HIV-1 strains, changes in the V3 variable 
region can result in a decreased association of gp120 with the Env trimer26.
A recent crystal structure of a neutralizing antibody, PG9, bound to the gp120 V1/V2 region 
expressed as a fusion with a heterologous scaffold protein suggested that V1/V2 can form 
secondary structures30. Perhaps because the V1/V2-scaffold protein is missing the gp120 
core and V3 region and was analyzed in a monomeric state, the V1/V2 segment of this 
structure does not fit into our cryo-EM density and therefore may not exhibit the V1/V2 
conformation in the unliganded trimer. Given the limited resolution of the present cryo-EM 
structure, any conclusion regarding the difference in V1/V2 structure between the 
unliganded trimer and the artificially engineered scaffold protein would be premature. 
However, both studies suggest some potentially common hypotheses that deserve further 
investigation. First, the V1/V2 and V3 regions are able to form secondary structures despite 
their variable nature. Second, the secondary structure(s) formed from V1/V2 and V3 might 
be metastable and might inter-convert between different forms, depending on the 
environment and structural context. Third, the overall architecture of the V1/V2 and V3 
structures should be conserved across different isolates to maintain the integrity of a 
functional Env trimer.
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gp41 trimer association
The transmembrane region of the gp41 trimer segregates as an entity distinct from the rest of 
the cryo-EM structure. The transmembrane segment of each gp41 protomer forms a rod-like 
shape with an approximate length of 3 nm (Fig. 5a,b). The diameter of the trimeric Env 
transmembrane region can accommodate a three-helix bundle. The extra density surrounding 
the three-helix bundle might be a mixture of detergents, glycans and protein components, 
and is not separable at this resolution.
In contrast to the tightly packed transmembrane regions, the three leaf-like shapes of the 
gp41 ectodomain spread out from the tripod base formed by the distal ends of three 
transmembrane rods. Approximately 2 nm from the viral membrane, two lobes of each ‘leaf’ 
transversely join the cognate elements of the neighbouring subunits to form a torus-like 
structure (Fig. 5c,d). The gp41 ectodomain extends obliquely to form an interface with the 
gp120 inner domain approximately 3 nm away from the base of the torus. The direct 
contacts between the gp120 and gp41 subunits within each protomer are apparently centered 
on a region approximately halfway along the height of the pyramidal ‘tetrahedron’.
In addition to the gp120 trimer association domain, the gp41 transmembrane region and 
ectodomain torus make interprotomer contacts that likely stabilize the trimeric Env cage, 
which bounds a central void surrounding the trimer axis. This central void in the unliganded 
Env complex contrasts with the densely packed trimeric coiled coil and six-helix bundle that 
surround the trimer axis of the pre-hairpin intermediate and post-fusion state, respectively. 
Neither the crystal structure of the post-fusion gp41 core trimer in a six-helix bundle 
conformation9-11 nor the deduced structure of the gp41 HR1 coiled coil fit into the gp41 
component of the cryo-EM density. The torus-like architecture instead indicates a different 
fold of the gp41 ectodomain in the unliganded Env precursor, and presumably in the 
proteolytically processed Env trimer as well. Such a model is consistent with studies of 
HIV-1 variants suggesting that the gp41 coiled coil is not formed in the Env trimer prior to 
CD4 binding31. Moreover, the gp41 ectodomain, and the HR1 region in particular, play 
roles in maintaining the non-covalent interaction with gp120 and sequestering the 
hydrophobic fusion peptide32-35. The contacts that the gp41 ectodomain makes in the 
unliganded Env trimer presumably keep the gp41 trimer from folding into downstream 
conformations.
Comparison with tomographic map of the virion Env spike
Comparison of our cryo-EM structure with the 20-Å electron tomographic map14,15 of the 
proteolytically processed36 and functional37 Env spike on HIV-1 virions indicates a 
remarkable agreement in overall architecture (Fig. 6). The general agreement of the density 
maps suggests that our methods to extract and purify the membrane-bound Env trimer 
preserve a conformation similar to that of the unliganded, pre-fusion conformation of the 
Env spike on the native virions. Previous studies found that uncleaved Env trimers bind 
poorly neutralizing antibodies better than proteolytically cleaved Env trimers38,39. However, 
at a resolution of 10-20 Å, any structural differences resulting from proteolytic cleavage are 
not apparent. Thus, consistent with studies suggesting that proteolytic processing occurs 
very late during HIV-1 Env movement through the secretory pathway3, the major quaternary 
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interactions that maintain trimer integrity are established before gp120-gp41 cleavage. 
Furthermore, any conformational changes in the Env ectodomain resulting from association 
with the viral membrane or the presence of the gp41 cytoplasmic tail40 are also too subtle to 
be detected at this level of resolution.
Comparing our cryo-EM structure to earlier tomographic maps14,15,17, one immediately 
senses the considerable enrichment of structural features resulting from an improved 
resolution. The cage-like architecture and the striking central void in the HIV-1 Env trimer 
become unambiguously manifest. This topology is unusual among viral envelope 
glycoproteins41 and likely contributes to HIV-1 immune evasion and persistence. By 
positioning conserved surfaces like the CD4-binding site on the inward-facing side of the 
protomeric leaves, the accessibility of antibodies to these sites is sterically restricted by the 
adjacent protomer. Other structural features evident in our cryo-EM map are not apparent in 
the tomographic map. Whether the 20-Å tomographic map is visualized at a low level (Fig. 
6a, b) or high level (Fig. 6c) of contour, the inter-domain cavity between the gp120 inner 
domain and outer domain is not visible. The six-way junction at the gp120 trimerization 
interface evident in our cryo-EM map is simplified into a three-way joint in the tomographic 
map. At a high level of contour (Fig. 6c), the density of the gp41 transmembrane region 
disappears in the 20-Å tomographic map, but is retained in our cryo-EM map at an 
amplitude comparable to that of the rest of the density. The 11-Å density map allows a clear-
cut visualization of the gp41 torus-like architecture over a wide range of contour levels. 
These differences in the resolvability of Env features reflect the expected improvement in 
the density map due to higher resolution, suggesting that the FSC at a 0.5-cutoff provides an 
appropriate estimation of resolution in this case.
DISCUSSION
In the absence of constraints imposed by the V1/V2 and V3 variable regions, the HIV-1 
gp120 core assumes the CD4-bound conformation42. Peptides corresponding to the heptad 
repeat regions (HR1 and HR2) of the gp41 ectodomain form a stable six-helix bundle in the 
absence of interactions with gp120 (refs. 9-11). Thus, outside of their structural context in 
the unliganded HIV-1 Env trimer, both gp120 and gp41 exhibit a propensity to assume 
conformations that are associated with downstream states on the virus entry pathway. Our 
cryo-EM map allows us to conclude that gp120 is not in the CD4-bound state in the 
unliganded Env precursor. The proposed location of the gp120 V1/V2 and V3 variable 
regions in the trimer association domain of the unliganded HIV-1 Env trimer is consistent 
with these variable regions restraining movement into the CD4-bound conformation by 
virtue of their interactions at the gp120 trimer interface. These interactions are likely 
disrupted upon CD4 binding as the Env trimer ‘opens’14. Changes in V1/V2 and V3 have 
been shown to render the HIV-1 Env more prone to assume the CD4-bound conformation 
spontaneously, allowing virus entry into cells expressing no CD4 or low levels of CD4 (refs. 
43-45).
The visualization of the HIV-1 gp41 ectodomain in our cryo-EM map allows us to rule out 
the presence of the gp41 six-helix bundle or the HR1 trimeric coiled coil at the trimer axis of 
the unliganded Env precursor. This conclusion is consistent with those of several previous 
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studies indicating that the formation of the HR1 trimeric coiled coil and the six-helix bundle 
are steps in virus entry that occur after CD4 binding31-34.
All approaches to higher-resolution structure determination require enrichment and 
preferably purification of the molecular complex of interest. The metastability of the HIV-1 
Env trimer creates significant challenges to the purification of Env complexes that retain a 
native conformation. Soluble gp140 glycoproteins that lack the gp41 transmembrane region 
and cytoplasmic tail are conveniently expressed and purified; however, the epitopes for the 
PG9/PG16 neutralizing antibodies, which are dependent upon Env quaternary structure, are 
disrupted in the soluble gp140 glycoproteins, suggesting that these proteins do not 
completely retain the native conformation of the unliganded Env trimer46.
As an alternative to the soluble gp140 glycoproteins, we explored approaches to solubilize 
and purify the membrane-bound HIV-1 Env trimer in a native conformation. We screened a 
wide spectrum of detergent candidates such as CHAPS, DDM (ndodecyl-β-D-maltoside), 
OG (β-octyl-D-glucoside), FOS-CHOLINE-12, etc. The detergent Cymal-5 was found to be 
best suited for Env trimer purification. Importantly, the membrane-bound HIV-1JR-FL 
E168K Env trimers purified by this approach are recognized by the PG16 antibody 
equivalently to cell-surface-expressed HIV-1JR-FL E168K Env trimers (Supplementary Fig. 
1b,c)49. The PG16 neutralizing antibody recognizes a gp120 epitope that is very sensitive to 
changes in the V1/V2 and V3 variable regions, in the associated glycans, and in the 
quaternary structure of the Env trimer30,46. Other conformation-dependent neutralizing 
antibodies, including VRC01 (refs. 47,48), b12 (ref. 7) and 2G12 (ref. 49), recognized the 
original HIV-1JR-FL Env(−)ΔCT glycoprotein and its E168K variant following purification 
(Supplementary Fig. 1). Thus, the approach that we developed to purify the membrane-
bound Env trimer largely preserves its conformational and structural integrity.
Although single-particle cryo-EM has achieved near-atomic resolution for highly symmetric 
icosahedral particles50, only a few cases have been reported for membrane protein structures 
at a resolution better than ~10 Å by single-particle cryo-EM51,52. One formidable barrier 
impeding single-particle cryo-EM reconstruction of membrane proteins at subnanometer 
resolution is the requirement for detergents. Detergents form nanometer-sized micelles in 
the protein solutions that may increase the background noise and further reduce the cryo-EM 
image contrast. In this study, we screened a number of combinations of detergent and 
solution configuration to maximize the image contrast prior to 3D reconstruction. The best 
imaging results were obtained by switching from Cymal-5 to Cymal-6 after Env(−)ΔCT 
purification and prior to imaging.
Our results demonstrate that the purified Env(−)ΔCT trimers are sufficiently homogeneous 
in conformation to allow an ~11-Å reconstruction by single-particle cryo-EM. In addition to 
the choice of detergents that maintain inter-protomer interactions and quaternary epitopes, 
our use of an uncleaved form of the Env trimer may also have contributed to conformational 
homogeneity. Indeed, it has been difficult to obtain homogeneous preparations of 
proteolytically processed wild-type HIV-1 Env trimers due to the lability of these 
complexes. Cleaved HIV-1 Env trimers have been stabilized by the introduction of an 
artificial disulfide bond between gp120 and gp41 (SOSgp160ΔCT)16,53. In some cases, the 
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alteration of a gp41 isoleucine residue to proline and deletion of the transmembrane region 
have been applied to SOSgp160ΔCT to create SOSIP soluble gp140 glycoproteins53. Both 
SOSgp160ΔCT and SOSIP soluble gp140 trimers have been studied by single-particle cryo-
EM or cryoelectron tomography approaches16,17,54. The 20-Å cryo-EM structure of the 
SOSgp160ΔCT trimer exhibits a tripod conformation, with an unclear assignment of the 
transmembrane region16. These dissimilarities between the SOSgp160ΔCT structure and our 
Env(−)ΔCT structure might result from differences, including proteolytic cleavage, between 
the Env constructs, their choice of Triton X-100 as a detergent, and/or their use of 
glutaraldehyde crosslinking16. The SOSIP soluble gp140 structure has been analyzed in two 
studies17,54. A 14-Å negative staining EM structure of the SOSIP gp140 trimer complexed 
with PGT antibodies demonstrated missing or weakened density around the gp120 trimer 
axis compared with our 11-Å Env(−)ΔCT structure54. The six-way junction in the 
Env(−)ΔCT structure has apparently collapsed and partially disappears in the 14-Å negative-
staining EM reconstruction of the SOSIP soluble gp140 trimer54. Similarly, a 20-Å 
resolution cryo-electron tomographic structure of the unliganded SOSIP soluble gp140 
trimer17 also exhibited rather weak density in the gp120 trimer association domain. The 
basis for the differences in the gp120 trimer association domain between the SOSIP soluble 
gp140 and the Env(−)ΔCT trimers will require further investigation; however, the poor 
recognition of the SOSIP soluble gp140 trimers by quaternary structure-dependent 
antibodies like PG16 (ref. 46) could potentially be explained by the metastability of the six-
way junction at the gp120-gp120 interfaces. The future availability of structural data at 
higher resolution for these different forms of Env should clarify these issues and expedite 
the improvement of Env trimer mimics as immunogens.
METHODS
Methods and any associated references are available in the online version of the paper.
ONLINE METHODS
Purification of the membrane-bound Env trimer
Then env cDNA was codonoptimised and subcloned into the pcDNA3.1(−) expression 
plasmid (Invitrogen). The Env(−)ΔCT glycoprotein contains a heterologous signal sequence 
from CD5 in place of the wild-type HIV-1 Env signal peptide. Site-directed mutagenesis 
was used to change the proteolytic cleavage site between gp120 and gp41, substituting Ser 
for Arg508 and Arg511. The Env cytoplasmic tail was truncated by introduction of a stop 
codon at Tyr712; a sequence encoding a (Gly)2(His)6 tag was inserted immediately before 
the stop codon. The plasmid expressing the Env(−)ΔCT glycoprotein was transfected into 
the 293F cells. After 36 h, cells expressing the envelope glycoproteins were harvested and 
washed with phosphate-buffered saline (PBS) at 4 °C. The cell pellets were homogenized in 
a homogenization buffer (250 mM sucrose, 10 mM Tris-HCl [pH 7.4]) and a cocktail of 
protease inhibitors [Roche Complete tablets]). The plasma membranes were then extracted 
from the homogenates by ultracentrifugation and sucrose gradient separation. The extracted 
crude plasma membrane pellet was collected and solubilized in a solubilization buffer 
containing 100 mM (NH4)2SO4, 20 mM Tris-HCl (pH 8), 300 mM NaCl, 20 mM imidazole, 
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1% (wt/vol) Cymal-5 (Affymatrix) and a cocktail of protease inhibitors (Roche Complete 
tablets). The membranes were solubilized by incubation at 4 °C for 30 min on a rocking 
platform. The suspension was ultracentrifuged for 30 min at 200,000 × g at 4 °C. The 
supernatant was collected and mixed with a small volume of pre-equilibrated Ni-NTA beads 
(QIAGEN) for 8-12 h on a rocking platform at 4 °C. The mixture was then injected into a 
small column and washed with a buffer containing 100 mM (NH4)2SO4, 20 mM Tris-HCl 
(pH 8), 1 M NaCl, 30 mM imidazole and 0.5% Cymal-5. The bead-filled column was eluted 
with a buffer containing 100 mM (NH4)2SO4, 20 mM Tris-HCl (pH 7.4), 250 mM NaCl, 
250 mM imidazole and 0.5% Cymal-5. The eluted Env glycoprotein solution was 
concentrated, diluted in a buffer containing 20 mM Tris-HCl, pH 7.4, 300 mM NaCl and 
0.01% Cymal-6, and reconcentrated to ~2.5 mg ml−1 prior to cryo-sample preparation. The 
recognition of the purified Env glycoproteins by a number of conformation-dependent 
antibodies, including VRC01, b12 and 2G12, as well as CD4-Ig, was measured in an 
enzyme-linked immunosorbent assay (ELISA) (see below). The VRC01 and b12 antibodies 
recognize conformation-dependent epitopes near the CD4-binding site of gp120 (refs. 7, 47, 
48). The 2G12 antibody recognizes a high-mannose glycan array on the gp120 outer 
domain49. CD4-Ig consists of the two N-terminal domains of CD4 fused to the Fc portion of 
the immunoglobulin heavy chain27. We also examined whether our Env solubilization and 
purification approach affected the integrity of an epitope that is recognized by the PG16 
antibody and that is sensitive to changes in the quaternary structure of the HIV-1 Env 
trimer46. To this end, we studied PG16 binding to the Env(−)ΔCT E168K glycoprotein. The 
wild-type HIV-1JR-FL isolate is highly resistant to neutralization by the PG16 antibody, but 
the E168K change renders the HIV-1JR-FL Env sensitive to PG16 (ref. 46). PG16 binding to 
the purified Env(−)ΔCT E168K glycoprotein was tested in the ELISA.
Enzyme-linked immunosorbent assay
A white, high-binding microtiter plate (Corning) was coated by incubating 0.5 μg of mouse 
anti-polyhistidine antibody (sc-53073, Santa Cruz Biotechnology) in 100 μl PBS in each 
well overnight. Wells were blocked with blocking buffer (5% non-fat dry milk [Bio-Rad] in 
20 mM Tris-HCl, pH 7.4 and 300 mM NaCl) for 2 h and then washed twice with wash 
buffer (20 mM Tris-HCl, pH 7.4 and 300 mM NaCl). Approximately 0.5 μg of purified Env 
trimer in blocking buffer was added to each well, the plate was incubated for 60 min and 
washed thrice with wash buffer. Different concentrations of specific Env ligands 
(conformation-dependent antibodies and the CD4-Ig fusion protein) in blocking buffer were 
added to the wells and the plate was incubated for another 45 min. After three washes, 
peroxidase-conjugated F(ab’)2 fragment donkey anti-human IgG (1:3600 dilution; Jackson 
ImmunoResearch Laboratories) in blocking buffer was added to each well. The plate was 
incubated for 30 min, washed six times, and 80 μl of SuperSignal chemiluminescent 
substrate (Pierce) was added to each well. The relative light units in each well were 
measured for two seconds with a Centro LB 960 luminometer (Berthold Technologies, TN). 
All procedures were performed at room temperature.
Flow cytometry
293T cells were transfected, by either calcium phosphate co-precipitation or by using the 
Effectene transfection reagent (Qiagen), with a plasmid encoding the Env(−)ΔCT E168K 
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glycoproteins. After 48 h, approximately half a million cells were analyzed by flow 
cytometry as previously described55, but with primary antibody incubation for 30 min, and 
secondary antibody (Allophycocyaninconjugated F(ab’)2 fragment donkey anti-human IgG 
antibody, Jackson ImmunoResearch Laboratories) incubation for 15 min, both at room 
temperature. Cells were analyzed with a BD FACSCanto II flow cytometer (BD 
Biosciences).
Cryo-EM reconstruction and model analysis
To prepare the cryo-sample for single-particle imaging, 2.5 μl of the 2.5 mg ml−1 
Env(−)ΔCT solution was spread on a C-flat holey carbon grid (Electron Microscopy 
Sciences) in a chamber of 100% humidity, held for 2 s, blotted by filter papers for 2 s at 4 
°C, and then flash-plunged into liquid ethane by Vitrobot (FEI). The prepared cryo-grids 
were transferred into the CT3500 cryo-transfer system (Gatan) in liquid nitrogen and were 
used for single-particle image data collection at −183 °C. Focus pairs of micrographs were 
recorded on a Tecnai F20 TEM (FEI) with a field-emission gun at 200 kV and a calibrated 
magnification of 200,835× on a 4k × 4k slow-scan CCD camera (Gatan). The electron dose 
of each exposure was 10.0 electrons Å−2. The defocus of the second set of micrographs 
differed from that of the first set by 1.0 μm. Micrographs were screened for drift, 
astigmatism and visibility of Thon rings in the power spectra. Parameters of the contrast 
transfer function (CTF) of each micrograph were determined with the CTFFind3 
program56,57. A total of 90,306 single-particle images (in a dimension of 320 × 320 pixels 
and a pixel size of 0.747 Å) selected from the closer-to-focus micrographs were used for 
reconstruction. Each single-particle image was decimated by 4 times to a dimension of 80 × 
80 pixels prior to further image analysis, resulting in a pixel size of 2.99 Å. The images were 
CTF-corrected by the phase flipping method. These single-particle images were then 
subjected to multivariate data analysis and classification. Images in each class were aligned 
in a reference-free manner and the class averages were refined by a maximum-likelihood 
approach20,21. These class averages were used to perform angular reconstitution to yield an 
initial model. The initial model was further refined by the projection-matching algorithm 
with C3 symmetry imposed. The angular increment was progressively decreased from 10° to 
1° in the refinement. For the last round of refinement, the new classes of images were re-
aligned by a maximum-likelihood approach20,21. The above image analysis was 
implemented in customized computational procedures and workflows, combining the 
functions of SPIDER, XMIPP and homemade FORTRAN programs58,59. The final 
reconstruction at 10.8 Å, measured by FSC-0.5 cutoff, was not corrected for its temperature 
factor. Segmentation of the cryo-EM density, fitting of crystal structures into the map and 
figure illustrations were done in UCSF Chimera60.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
The cryo-EM structure of the membrane-bound HIV-1 Env trimer at ~11-Å resolution. (a) 
The reconstruction of the HIV-1JR-FL Env(−)ΔCT trimer is shown as a solid surface viewed 
from a perspective parallel to the viral membrane. The approximate boundaries of the 
transmembrane region and ectodomain are indicated. (b) The Env trimer reconstruction is 
visualized at two different levels of contour. The lower and higher levels of contour are 
illustrated as a meshwork and a solid surface representation, respectively. (c) The Env trimer 
reconstruction in a solid surface representation is viewed from the perspective of the target 
cell, at the same contour level as that shown in a. (d) The Env trimer reconstruction is 
shown at two different levels of contour in the same way as in b, viewed from the 
perspective of the target cell. (e) The images show typical reference-free class averages 
produced by maximum-likelihood alignment with no C3 symmetry imposed. Scale bar, 10 
nm. See Supplementary Figures 3 and 4 and Supplementary Movies 2 and 3 for more 
details.
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Figure 2. 
The map segmentation of an Env protomer. (a, b) The map segmentation of an Env 
protomer in solid surface representation is wrapped in a meshwork representation of the Env 
timer, viewed from a perspective parallel to the viral membrane. Two different Env 
protomers are segmented in a and b. The segments approximately correspond to the 
indicated gp120 and gp41 domains. The red dashed circle indicates the approximate position 
of the CD4-binding site on the gp120 subunit. (c) The segmentation is viewed from the 
perspective of the target cell.
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Figure 3. 
Fit of the crystal structure of CD4-bound gp120 core into the cryo-EM density of the 
unliganded Env trimer in two different configurations. (a, b) The CD4-bound gp120 core 
structure (PDB ID: 3JWD)8 can fit into the local Env trimer cryo-EM density identified by 
segmentation as the gp120 inner domain and outer domain (See Fig. 2). This fitting 
configuration represents the best fit of the gp120 core crystal structure, taking into account 
both the inner and outer domains. The cryo-EM density is shown as a meshwork 
representation. The red arrow in a marks the interdomain cavity in the gp120 subunit. The 
gp120 core is missing the V1/V2 and V3 variable regions8. The inner domain and outer 
domain of the gp120 core crystal structure are coloured orange and dark blue, respectively. 
A fraction of the residues of the gp120 outer domain does not fit in the cryo-EM density in 
this fitting configuration, suggesting conformational differences between the unliganded and 
CD4-bound states. (c, d) The gp120 outer domain from the CD4-bound gp120 core 
structure8 was fitted into the cryo-EM density of the Env trimer, without consideration of 
the fit of the gp120 inner domain. This allows a much better fitting of the gp120 outer 
domain than that seen in a and b; only the LV5 variable loop has a few residues out of the 
cryo-EM density. Under the same fitting configuration, the inner domain of the CD4-bound 
gp120 core is largely outside the Env trimer cryo-EM density (not shown). This observation 
suggests that the gp120 inner domain rotates with respect to the outer domain upon binding 
CD4.
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Figure 4. 
The gp120 trimer association domains. (a) The segmented local densities of gp120 that 
associate near the trimer axis are shown as solid surfaces wrapped in a meshwork 
representing the overall Env trimer, viewed from the perspective of the target cell. Note the 
central triangular junction (yellow) with a diameter of around 1.5 nm. (b) The gp120 trimer 
association domain segments are viewed from the perspective of the viral membrane. Three 
arms extend from the V3 base of each gp120 subunit toward the trimer axis and appear to 
support the central triangular junction. The approximate positions of the V1/V2 stem and V3 
base are labelled in a and b. (c) The gp120 trimer association domain segments are viewed 
from a perspective parallel to the viral membrane.
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Figure 5. 
Architecture of gp41 trimer association. (a, b) The gp41 segments are shown as solid 
surfaces wrapped in a meshwork representing the overall Env trimer, viewed from a 
perspective parallel to the viral membrane (a) and from the perspective of the viral 
membrane (b). (c, d) The gp41 ectodomain segments that form the torus and contribute to 
interprotomer interactions are shown. The views are from a perspective parallel to the viral 
membrane (c) and from the perspective of the viral membrane (d).
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Figure 6. 
Comparison of the 11-Å cryo-EM structure of the trimeric HIV-1 Env precursor with the 20-
Å electron tomographic model of the native HIV-1 Env trimer on virions. (a) The 20-Å 
model of the HIV-1 Env trimer on virions (grey surface)14 and the 11-Å model of the HIV-1 
Env precursor (cyan surface) are superimposed, using the trimer axis as a common 
reference. Both models are shown at a comparable level of contour. (b) The same models 
and levels of contour as in a are shown, but the 20-Å tomographic model of the virion Env 
trimer is shown as a transparent grey surface. (c) The 11-Å cryo-EM model (left) and the 20-
Å tomographic model (right) are visualized side by side as solid surface representations at 
higher levels of contour than those shown in a and b. Upper and lower inserts show the 
superposition of the two models, with the 11-Å cryo-EM model shown as a meshwork 
representation and the 20-Å tomographic model as a transparent surface representation.
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